التفاصيل البيبلوغرافية
| العنوان: |
Response to Martani, Tomasi, and Casanto. |
| المؤلفون: |
Master, Zubin, Adjei, Alex A, Hargraves, Ian G, Montori, Victor M, Tilburt, Jon C |
| المصدر: |
JNCI: Journal of the National Cancer Institute; Mar2021, Vol. 113 Issue 3, p340-341, 2p |
| مصطلحات موضوعية: |
PSYCHO-oncology, PSYCHOLOGICAL distress, BIOETHICS |
| مستخلص: |
Martani and colleagues have unpacked perhaps the most concerning aspect about Right-to-Try (RTT) laws: declamatory statements in the name itself proclaim a false sense of what the law is attempting to do rather than what it actually does (1) - something with which we wholeheartedly agree. Private equity supported, for-profit cancer centers charging patient members for "unique access" to experimental therapeutics through RTT further complicate open and honest conversations (3). Such an approach extends clinician RTT education and brings experimental therapies into the regular care of patients with life-threatening cancer. [Extracted from the article] |
|
Copyright of JNCI: Journal of the National Cancer Institute is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder